Marijuana and Medicinal Cannabis
In November 2016, the Epilepsy Society of Australia issued a position statement concerning Marijuana and Medicinal Cannabis in the treatment of epilepsy.
To access the position statement, click below:
- Devinsky et.al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med 376;21
- Thiele et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 391
This page was last reviewed in May 2018.